Shares of Aveanna Healthcare Holdings Inc. (AVAH) tumbled 12.38% in pre-market trading on Thursday, November 6, 2025, despite the company reporting better-than-expected third-quarter results and raising its full-year guidance.

The home healthcare provider announced Q3 revenue of $621.9 million, surpassing analyst estimates of $592.2 million. Aveanna also reported a net income of $14.1 million, or $0.06 per share, marking a significant turnaround from the net loss reported in the same quarter last year.

In light of the strong performance, Aveanna raised its full-year 2025 revenue guidance to over $2.375 billion, up from its previous forecast of over $2.3 billion. The company also increased its adjusted EBITDA guidance to more than $300 million, compared to the earlier projection of over $270 million.

Despite these positive developments, investors seemed to react negatively to the news, sending the stock sharply lower before the market open. The stark contrast between the company's reported results and the stock's performance suggests that market expectations may have been even higher or that other factors are influencing investor sentiment.

As the trading day progresses, it remains to be seen whether Aveanna's stock will recover from this initial plunge or if concerns about the company's future prospects will overshadow the strong quarterly results and improved outlook.